STRIVE Reporting

STRIVE is a randomised community trial to control sexually transmitted infections in remote Aboriginal communities in northern and central Australia.

Objectives of STRIVE

Primary:

(1) To determine whether targeted clinical review and support provided to health services can achieve substantive and sustained improvements in the provision of sexual health clinical services in remote Aboriginal communities.

(2) To determine whether the attainment of best practice levels in clinical activity can reduce the prevalence of STIs in these communities.

Secondary:

(1) To measure the impact of the STRIVE trial on health service staff.

(2) To measure other non-STRIVE activities which may influence sexual health service delivery

Reports

These are currently being distributed to participating health services as required.

Prerequisites

  1. STI screening is recorded using the clinical item 'STI Screening [STATE]' with an export code of 'STI-SCR'.
  2. Screenings for asymptomatic patients should have the first 'STI signs and symptoms' qualifier set to 'Asymptomatic'.
  3. Pathology requests must be for tests found using the keyword of 'STI'.
  4. Abnormal results must be recorded using the Yes/No qualifiers for the specific infection (e.g. 'Chlamydia result abnormal') . These are offered in the pathology review if either the lab returns a known code or the result is matched to one of the known tests (see 3 above).
  5. Treatment must be recorded using the clinical item 'STI Treatment [STATE] with an export code of 'STI-TRT'.
  6. In all cases as much information as is required on the screening or treatment items should be provided.
  7. The reports at Report > STI make reasonable attempts to find the data relating to a screening, pathology request, result, result review, treatment and subsequent screening. The time sequence is not always linear and not always complete.